Semaglutide

Hyderabad-based Natco Pharma has received approval from the Central Drugs Standard Control Organisation to manufacture and market generic semaglutide in India.
Semaglutide:
A GLP-1 receptor agonist that mimics a gut hormone to increase insulin and lower blood sugar.
Used for Type 2 diabetes management.
Reduces cardiovascular and kidney risks.
Aids weight loss in obese/overweight individuals.